Founded in 1996, J-Star Research has assembled one of the most talented and experienced chemical process teams in the industry.
Contract Services & Capabilities
J-Star Research offers a wide range of small molecule chemistry capabilities and technologies, including:
![smaller-CP5A1321 smaller-CP5A1321](https://www.jstar-research.com/storage/bb-plugin/cache/smaller-CP5A1321-e1673192011268-1024x514-panorama-4b9a9c39a67c8ada1d2d0898640e298c-.jpg)
Process Chemistry Research & Development
The management team and staff at J-STAR have extensive experience in pharmaceutical process research and development that spans many decades of practical, hands on expertise. Clients seeking to improve troublesome steps in a process, reduce the cost of goods by removing expensive or poorly performing steps, or re-design an entire route for one of their potential products or key intermediates, will find value added input at the chemistry level from the team at J-STAR.
![JS-C-8092 JS-C-8092](https://www.jstar-research.com/storage/bb-plugin/cache/JS-C-8092-1024x579-panorama-41072cbf5ff32d98fffe59c00dc9dc04-.jpg)
Drug Product Development
With the ability to develop both Drug Substance (DS) and Drug product (DP) under the same umbrella, our team enjoys a synergism absent in most CROs. The ability to bridge the DS/DP interface is a major competitive advantage in our ability to shorten development timeline and improve ruggedness of the DP process.
![smaller-5G5A5377 smaller-5G5A5377](https://www.jstar-research.com/storage/bb-plugin/cache/smaller-5G5A5377-1024x569-panorama-d79e6fa5fad078787bfcb2f3e5175376-.jpg)
cGMP Intermediate & API Production
Once a practical synthetic route has been demonstrated and the critical process research required for scale-up has been performed, J-STAR can then provide API prepared under cGMP guidelines to support Phase I human clinical trials. This is typically done after supplying material for GLP toxicology studies.